OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Crohns & Colitis is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment	289
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update	247
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease	167
The Burden of Inflammatory Bowel Disease in Europe in 2020	159
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology	97
Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultraso	79
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce	76
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience	70
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment	68
Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease	65
Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review	65
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial	63
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study	62
European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation	60
Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study	59
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study	58
Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients’ Perspective	58
Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review	56
Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease—A Danish Prospective Population-based Cohort Study	55
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry	55
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study	53
Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease	53
M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis	52
Development and Validation of a Simple Ultrasound Activity Score for Crohn’s Disease	51
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension	49

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines	48
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial	47
Automated Detection of Crohn’s Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks	45
Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease	44
Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus	44
Point-of-Care Ultrasound in Inflammatory Bowel Disease	43
A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn’s Disease in Remission	43
Degree of Creeping Fat Assessed by Computed Tomography Enterography is Associated with Intestinal Fibrotic Stricture in Patients with Crohn’s Disease: A Potentially Novel Mesenteric Creeping Fat Index	42
Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement	41
A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis	40
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD	40
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study	40
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2—a Comparative Study	40
Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index	39
Matrix Metalloproteinase MMP-12 Promotes Macrophage Transmigration Across Intestinal Epithelial Tight Junctions and Increases Severity of Experimental Colitis	39
Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients	39